Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival

This publication has 6 references indexed in Scilit:

• Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist de vice
  The Lancet, 1999
• Early Activation of Hepatic NFκB and NF-IL6 in Polymicrobial Sepsis Correlates With Bacteremia, Cytokine Expression, and Mortality
  Annals of Surgery, 1999
• Preformed IgG Antibodies Against Major Histocompatibility Complex Class II Antigens Are Major Risk Factors for High-grade Cellular Rejection in Recipients of Heart Transplantation
  Circulation, 1998
• Factors Influencing HLA Sensitization in Implantable LVAD Recipients
  The Annals of Thoracic Surgery, 1997
• Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome?
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial
  Blood, 1991